Lexaria Bioscience Corp. (LEXX) vs Pulmatrix, Inc. (PULM)
A side-by-side comparison of Lexaria Bioscience Corp. and Pulmatrix, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LEXX
Lexaria Bioscience Corp.
$3.24HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PULM
Pulmatrix, Inc.
$1.43HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — LEXX vs PULM
growth of $100 · dividends reinvested · last 6yLEXX -95.9% (-41.2%/yr)PULM -94.4% (-38.2%/yr)PULM compounded faster over this window
LEXX PULM
LEXX vs PULM: by the numbers
- •LEXX is the larger company ($5M vs $5M market cap).
- •Both run net losses; PULM's is the smaller (0.00% vs -3985.58% net margin).
Metrics side by side
Valuation
| Metric | LEXX | PULM |
|---|---|---|
| P/S ratio | 27.60 | N/A |
| P/B ratio | 1.13 | 3.28 |
Profitability
| Metric | LEXX | PULM |
|---|---|---|
| Gross margin | 100.00% | 0.00% |
| Operating margin | -1683.01% | 0.00% |
| Net margin | -3985.58% | 0.00% |
| ROE | -163.18% | -156.94% |
| ROIC | -175.26% | -160.81% |
Growth (annualized)
| Metric | LEXX | PULM |
|---|---|---|
| Revenue CAGR (5Y) | 12.92% | N/A |
| Total return CAGR (5Y) | -50.86% | -37.13% |
Frequently asked
- How have LEXX and PULM total returns compared?
- Over the past 5 years, LEXX delivered -50.86% and PULM delivered -37.13% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.